Moderators and speakers of the 9th AMR Conference
Abdulrhman Mohana
Consultant, Senior Health Expert, Communicable Diseases, Public Health Authority of Saudi Arabia
Abi Manesh
Associate Professor, Christian Medical College, Vellore
Adam Johnson
Senior Microbiologist, Centauri Therapeutics
Akhil Bansal
Founder, AMR Funding Circle & Policy Fellow, Center for Global Development
Alasdair MacGowan
Consultant in Infection Research, North Bristol NHS Trust
Aleksandar Danilovski
Founder and Managing Partner, DALISCO d.o.o.
Alexander Krause
Director Global Market Access, bioMérieux SA
Alexandra Cameron
Senior Expert, Unit Head A.I. Impact Initiatives and Research Coordination, AMR Division, World Health Organization
Alireza Shamaei-Tousi
Principal Clinical Scientist, Debiopharm International
Andreas Diacon
Chief Scientific Officer, TASK
Anouk Muller
Consultant Clinical Microbiologist, Haaglanden Medical Centre
Astrid Pentz-Murr
Scientific Affairs Senior Manager, GARDP
Aula Abbara
Consultant in Infectious Diseases, Imperial College London
Becky McCall
PhD candidate, University College London
Bernhard Krismer
Senior Scientist, University of Tübingen
Caline Mattar
Associate Professor of Medicine, Washington University
Carmen Coxon
Regulatory Scientist, UK Medicines and Healthcare Products Regulatory Agency (MHRA)
Caterina Bissantz
Expert Scientist, F. Hoffmann-La Roche
Cédric Govaerts
Founder and CEO, Santero Therapeutics
Chandrasekhar Nair
Director and CTO, Molbio Diagnostics Ltd.
Christoph Dehio
Full Professor of Molecular Microbiology, Director of National Centre of Competence in Research (NCCR) “AntiResist”
Clare Nasmyth-Miller
Global Development Leader, F. Hoffmann-La Roche Ltd
Diane Shader Smith
Health advocate and author, Global AMR Diary
Elda Righi
Infectious Diseases physician, Guy's and St Thomas' NHS Foundation Trust
Florence Séjourné
CEO, Aurobac Therapeutics & Treasurer, BEAM Alliance
Florian Kloss
Head of Chemistry, Basilea Pharmaceutica International Ltd
Francesca Chiara
Chair, The AMR Narrative
Glenn E. Dale
Chief Development Officer, BioVersys AG
Grace Hampson
Associate Director, Office of Health Economics
Herbert Wetli
Head of Pharmaceutical Development, GARDP
Holger Rohde
Deputy Director, Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf
Ingrid Wanninger
Managing Director, HYpharm GmbH
Jasper Claessen
Team coordinator – Policies for Research and Availability of Medicines, Dutch Ministry of Health
Jens Hellwage
Managing Director, InfectoGnostics Research Campus Jena
Kate Grailey
Behavioural Research Lead, Fleming Initiative
Katie Young
Initiative Lead, Healthcare System Transformation, World Economic Forum
Kevin Outterson
Austin B Fletcher Professor, Boston University, and Executive Director & Principal Investigator, CARB-X
Kristina Osbjer
Director of Science, International Centre for Antimicrobial Resistance Solutions (ICARS)
Leander Grode
Managing Director, Serum Life Science Europe GmbH
Lloyd Payne
Venture Partner, Kineticos Life Sciences AMR Fund
Marc Bonten
CEO, European Clinical Research Alliance on Infectious Diseases (ECRAID)
Marc Gitzinger
CEO, BioVersys AG & President, BEAM Alliance
Marianne Ismail
Co-founder, Director and CEO, Microbira Ltd.
Mark Jones
Head of Global Affairs, Basilea Pharmaceutical International, Allschwill Ltd.
Markus Zeitlinger
Professor, Specialist in Internal Medicine and Clinical Pharmacology, Medical University of Vienna
Megan Neary
Senior Research Manager for Therapeutics, Wellcome Trust
Najy Alsayed
Global Therapeutic Area Head for Infectious Diseases, Menarini Group
Nour Shamas
Member of the WHO Task Force of AMR survivors
Olga Tosas Auguet
Epidemiologist, World Health Organization
Peter Beyer
Deputy Executive Director, GARDP Foundation
Philippe Herman
Founder & CEO, IMMUNOCHEM
Pol Vandenbroucke
VP Global Government Affairs, Shionogi Inc.
Radu Botgros
Senior Scientific Officer, European Medicines Agency
Remko van Leeuwen
CEO, SurvivX
Richard Alm
Chief Scientific Officer, CARB-X
Richard Grohs
Scientist, Leibniz Institute of Photonic Technology
Rienk Pypstra
Chief Medical Officer & Head of Infectious Diseases, tranScrip
Robert Skov
President, ESCMID & Senior Consultant, Statens Serum Institut
Rolf Müller
Managing Director, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
Sarah Tschudin Sutter
Head Division of Infectious Diseases, University Hospital Basel
Saskia Janssen
Consultant in Infectious Diseases, TASK Clinical Research Centre
Sebastian Hiller
Professor for Structural Biology and Biophysics at Biozentrum, University of Basel
Sibyl Anthierens
Professor, University of Antwerp
Stefan Hagel
Assistant Medical Director; Institute for Infectious Diseases and Infection Control, Jena University Hospital
Stéphane Gavoille
CEO & Market Access Director, MOLSID
Stephanie Buurman
Technical Development Leader, F. Hoffmann-La Roche Ltd.
Taslimarif Saiyed
CEO and Director, Centre for Cellular and Molecular Platforms (C-CAMP)
Teri Roberts
Senior Public Health Manager, GARDP
Tobi Nagel
Founder and President, Phages for Global Health
Toby Leslie
Global Technical Lead, Fleming Fund / Mott MacDonald
Ursula Theuretzbacher
Founder, Center for Anti-Infective Agents
Usman Nakakana
Senior Program Officer Vaccine Development and Impact, Gates Foundation
Victoria Rutter
CEO, Commonwealth Pharmacists Association
Wolfgang Philipp
Acting Deputy Head HERA, European Commission
Yewande Alimi
One Health Unit Lead, Africa CDC
Yuping Li
Assistant Professor, University of Basel
Zhenkun Ma
Founder and CEO, TenNor Therapeutics
Zina Affas Besse
Deputy Head Healthcare Private Equity, AXA Investment Managers